Triple versus Dual Inhaler therapy in moderate ‐to‐severe COPD: A systematic review and meta‐analysis of randomized controlled trials

ConclusionsAmong patients with moderate ‐to‐severe COPD, triple inhaler therapy was associated with a reduction of moderate‐to‐severe COPD exacerbations, improved lung function, and improved quality of life when compared to dual inhaler therapy but with an increased pneumonia risk.This article is protected by copyright. All rights reserved.Key wordsCOPD, triple inhaler, dual inhaler, meta ‐analysis.

Source: The Clinical Respiratory Journal - April 3, 2019 Category: Respiratory Medicine Authors: Yazan Zayed, Mahmoud Barbarawi, Babikir Kheiri, Tarek Haykal, Adam Chahine, Laith Rashdan, Kewan Hamid, Saira Sundus, Momen Banifadel, Ahmed Aburahma, Ghassan Bachuwa, Arul Chandran Tags: Review Article Source Type: research